Landscapes / Companies
Supernus Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 10 in all
Trials
7 active
48 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Attention-Deficit/Hyperactivity Disorder | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Dec 2026Phase 1/2 trial completes | |||
| Next date | 30 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Focal Onset Seizures, Focal Impaired Awareness Seizures and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2026Phase 2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Major Depressive Disorder (MDD) | ||||
| Open drug page | |||||
About
- No active trial
- 7 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021